Mazdutide Shows Significant Weight Loss in Phase 3 Trial
Key Summary Mazdutide, a dual GLP-1 and glucagon receptor agonist, achieved 16.65% mean weight loss in adults with obesity. 84.3%…
Edition: International
Wednesday 10 June, 2026
Trending
Mazdutide Shows Significant Weight Loss in Phase 3 Trial
Key Summary Mazdutide, a dual GLP-1 and glucagon receptor agonist, achieved 16.65% mean weight loss in adults with obesity. 84.3%…
Medical Innovations
Phage Therapy Study Reveals RNA-Based Infection Control
Key Takeaways (Quick Summary) Researchers uncovered how bacteriophages use a small RNA molecule (PreS) to control bacterial gene expression. PreS…
COVID-19
Study Reveals Cold May Impact SARS-CoV-2 Infection Rates
The Unexpected Protective Role of Rhinoviruses in COVID-19 A groundbreaking study from National Jewish Health has revealed an intriguing phenomenon:…
Heart, Lung, & Brain Risks Persist in COVID-19 Survivors
A French nationwide study reveals that individuals hospitalized with COVID-19 remain at an increased risk of death and organ-related complications…
How COVID-19 and Vaccines Differ in Heart Inflammation
A team of international researchers led by the Max Delbrück Center for Molecular Medicine in Berlin has identified distinct immune…
Health and Wellness
Mazdutide Shows Significant Weight Loss in Phase 3 Trial
Key Summary Mazdutide, a dual GLP-1 and glucagon receptor agonist, achieved 16.65% mean weight loss in adults with obesity. 84.3%…
Ozone Pollution Reduces Exercise Benefits in Children
Key Summary Vigorous physical activity supports lung growth in children aged 6 to 9. Long-term ozone pollution exposure reduces these…
Walking 8,500 Steps May Prevent Weight Regain
Key Points A new meta-analysis presented at the European Congress on Obesity 2026 found that walking around 8,500 steps daily…